Executive Summary
This premier specialized manufacturer operates at the critical intersection of aviation and emergency medical services (EMS). The company owns one of the industry's most extensive portfolios of regulatory approvals, providing a "turnkey" platform for an investor or strategic buyer to dominate the aeromedical equipment market. This opportunity creates a fantastic opportunity via marketing and associated industry needs to capitalize on a lifetime of aircraft modification experience and expertise.

THE OPPORTUNITY AT A GLANCE
• The Regulatory "Moat": 220+ FAA-Approved Supplemental Type Certificates (STCs). These proprietary assets represent millions in sunk R&D costs and years of regulatory hurdles, creating a massive barrier to entry for competitors.
• Mission-Critical Products: Primary provider of aircraft/helicopter medical units and stretchers. 90% of revenue is derived from essential, life-saving equipment.
• Turnkey Operations: Fully equipped 7,800 sq. ft. facility with a highly skilled, stable team of 5 technicians. Capacity exists to scale production immediately without significant CAPEX.
• Blue-Chip Clientele: Diversified national footprint serving major aircraft OEMs, HEMS providers, and government agencies. Low customer concentration with high repeat business.

FINANCIAL & OPERATIONAL HIGHLIGHTS
Feature: Detail
YE 2025: Revenue $457,000, SDE $103,517
Asset Value: 220+ STCs Estimated development cost of at least $7.7m ($35K–$55K each STC), further Business Assets of $594k, plus the Operating Property at $875k
Outreach: STC’s cover many aircraft & helicopters across many global regions
Location: Established manufacturing facility with modern tooling
Stability: Recession-resistant demand from essential medical services

KEY VALUE DRIVERS & GROWTH CHANNELS
• Untapped Marketing: Historically driven by word-of-mouth; immediate upside through a dedicated sales force and digital presence.
• Service Revenue: Significant opportunity to capture high-margin recurring revenue via MRO (Maintenance, Repair, and Overhaul) contracts.
• Global Export: The STC portfolio is primed for international expansion into the European and Latin American aeromedical markets.
• Product Evolution: Leverage existing IP to develop new configurations for next-generation electric vertical take-off and landing (eVTOL) aircraft.

Wishing to retire soon, the owner is offering the sale of all business assets, and goodwill for $2.5M, and the Company’s operating property for an additional $875k.